Kang-Shun Zhu (Kangshun Zhu)

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 24

Top Topics

Radiofrequency Ablation

Top Venues

Cell death & disease

Liver international : official journal of the International Association for the Study of the Liver

Journal for immunotherapy of cancer

Clinical and translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Mingyue Cai, Wensou Huang, Wei Liang, Yongjian Guo, Licong Liang, Liteng Lin, Lulu Xie, Jingwen Zhou, Ye Chen, Bihui Cao, Jingqiang Wu, Kang-Shun Zhu
Lenvatinib, sintilimab plus transarterial chemoembolization for advanced stage hepatocellular carcinoma: A phase II study. Liver international : official journal of the International Association for the Study of the Liver (2024)
Mingyue Cai, Wensou Huang, Wei Liang, Yongjian Guo, Licong Liang, Liteng Lin, Lulu Xie, Jingwen Zhou, Ye Chen, Bihui Cao, Jingqiang Wu, Kang-Shun Zhu
Lenvatinib, sintilimab plus transarterial chemoembolization for advanced stage hepatocellular carcinoma: A phase II study. Liver international : official journal of the International Association for the Study of the Liver 44 (4) (2024)
Mingyue Cai, Wensou Huang, Wei Liang, Yongjian Guo, Licong Liang, Liteng Lin, Lulu Xie, Jingwen Zhou, Ye Chen, Bihui Cao, Jingqiang Wu, Kang-Shun Zhu
Lenvatinib, sintilimab plus transarterial chemoembolization for advanced stage hepatocellular carcinoma: A phase II study. Liver international : official journal of the International Association for the Study of the Liver 44 (4) (2024)
Mingyue Cai, Wensou Huang, Wei Liang, Yongjian Guo, Licong Liang, Liteng Lin, Lulu Xie, Jingwen Zhou, Ye Chen, Bihui Cao, Jingqiang Wu, Kang-Shun Zhu
Lenvatinib, sintilimab plus transarterial chemoembolization for advanced stage hepatocellular carcinoma: A phase II study. Liver international : official journal of the International Association for the Study of the Liver 44 (4) (2024)
Mingyue Cai, Wensou Huang, Wei Liang, Yongjian Guo, Licong Liang, Liteng Lin, Lulu Xie, Jingwen Zhou, Ye Chen, Bihui Cao, Jingqiang Wu, Kang-Shun Zhu
Lenvatinib, sintilimab plus transarterial chemoembolization for advanced stage hepatocellular carcinoma: A phase II study. Liver international : official journal of the International Association for the Study of the Liver 44 (4) (2024)
Xiaobin Wang, Qiaoyun Zhang, Jingwen Zhou, Zecong Xiao, Jianxin Liu, Shaohui Deng, Xiaoyang Hong, Wensou Huang, Mingyue Cai, Yongjian Guo, Jingjun Huang, Yong Wang, Liteng Lin, Kang-Shun Zhu
T cell-mediated targeted delivery of tadalafil regulates immunosuppression and polyamine metabolism to overcome immune checkpoint blockade resistance in hepatocellular carcinoma. Journal for immunotherapy of cancer 11 (2) (2023)
Mingyu Liu, Lulu Xie, Yuying Zhang, Jianning Chen, Xiang Zhang, Ye Chen, Wensou Huang, Mingyue Cai, Licong Liang, Miaoling Lai, Jingjun Huang, Yongjian Guo, Liteng Lin, Kang-Shun Zhu
Inhibition of CEMIP potentiates the effect of sorafenib on metastatic hepatocellular carcinoma by reducing the stiffness of lung metastases. Cell death & disease 14 (1) (2023)
Mingyu Liu, Lulu Xie, Yuying Zhang, Jianning Chen, Xiang Zhang, Ye Chen, Wensou Huang, Mingyue Cai, Licong Liang, Miaoling Lai, Jingjun Huang, Yongjian Guo, Liteng Lin, Kang-Shun Zhu
Inhibition of CEMIP potentiates the effect of sorafenib on metastatic hepatocellular carcinoma by reducing the stiffness of lung metastases. Cell death & disease 14 (1) (2023)
Xiao-Hui Wang, Chang-Jun Liu, Hao-Quan Wen, Xiao-Hui Duan, Yu-Qing Jiao, Yu-Jiang Liu, Min-Shan Chen, Kang-Shun Zhu, Xian-Hai Mao, Qun-Fang Zhou
Effectiveness of lenvatinib plus immune checkpoint inhibitors in primary advanced hepatocellular carcinoma beyond oligometastasis. Clinical and translational medicine 13 (3) (2023)
Xiaobin Wang, Qiaoyun Zhang, Jingwen Zhou, Zecong Xiao, Jianxin Liu, Shaohui Deng, Xiaoyang Hong, Wensou Huang, Mingyue Cai, Yongjian Guo, Jingjun Huang, Yong Wang, Liteng Lin, Kang-Shun Zhu
T cell-mediated targeted delivery of tadalafil regulates immunosuppression and polyamine metabolism to overcome immune checkpoint blockade resistance in hepatocellular carcinoma. Journal for immunotherapy of cancer 11 (2) (2023)
Mingyu Liu, Lulu Xie, Yuying Zhang, Jianning Chen, Xiang Zhang, Ye Chen, Wensou Huang, Mingyue Cai, Licong Liang, Miaoling Lai, Jingjun Huang, Yongjian Guo, Liteng Lin, Kang-Shun Zhu
Inhibition of CEMIP potentiates the effect of sorafenib on metastatic hepatocellular carcinoma by reducing the stiffness of lung metastases. Cell death & disease 14 (1) (2023)
Xiaobin Wang, Qiaoyun Zhang, Jingwen Zhou, Zecong Xiao, Jianxin Liu, Shaohui Deng, Xiaoyang Hong, Wensou Huang, Mingyue Cai, Yongjian Guo, Jingjun Huang, Yong Wang, Liteng Lin, Kang-Shun Zhu
T cell-mediated targeted delivery of tadalafil regulates immunosuppression and polyamine metabolism to overcome immune checkpoint blockade resistance in hepatocellular carcinoma. Journal for immunotherapy of cancer 11 (2) (2023)
Mingyu Liu, Lulu Xie, Yuying Zhang, Jianning Chen, Xiang Zhang, Ye Chen, Wensou Huang, Mingyue Cai, Licong Liang, Miaoling Lai, Jingjun Huang, Yongjian Guo, Liteng Lin, Kang-Shun Zhu
Inhibition of CEMIP potentiates the effect of sorafenib on metastatic hepatocellular carcinoma by reducing the stiffness of lung metastases. Cell death & disease 14 (1) (2023)
Mingyu Liu, Lulu Xie, Yuying Zhang, Jianning Chen, Xiang Zhang, Ye Chen, Wensou Huang, Mingyue Cai, Licong Liang, Miaoling Lai, Jingjun Huang, Yongjian Guo, Liteng Lin, Kang-Shun Zhu
Inhibition of CEMIP potentiates the effect of sorafenib on metastatic hepatocellular carcinoma by reducing the stiffness of lung metastases. Cell death & disease 14 (1) (2023)
Xiaobin Wang, Qiaoyun Zhang, Jingwen Zhou, Zecong Xiao, Jianxin Liu, Shaohui Deng, Xiaoyang Hong, Wensou Huang, Mingyue Cai, Yongjian Guo, Jingjun Huang, Yong Wang, Liteng Lin, Kang-Shun Zhu
T cell-mediated targeted delivery of tadalafil regulates immunosuppression and polyamine metabolism to overcome immune checkpoint blockade resistance in hepatocellular carcinoma. Journal for immunotherapy of cancer 11 (2) (2023)
Ye Chen, Jiaxin Bei, Meijuan Chen, Weiguo Cai, Zhimei Zhou, Mingyue Cai, Wensou Huang, Liteng Lin, Yongjian Guo, Mingyu Liu, Xinkun Huang, Ze-Cong Xiao, Zhili Xu, Kang-Shun Zhu
Intratumoral Lactate Depletion Based on Injectable Nanoparticles-Hydrogel Composite System Synergizes with Immunotherapy Against Post-Ablative Hepatocellular Carcinoma Recurrence. Advanced healthcare materials (2023)
Mingyu Liu, Lulu Xie, Yuying Zhang, Jianning Chen, Xiang Zhang, Ye Chen, Wensou Huang, Mingyue Cai, Licong Liang, Miaoling Lai, Jingjun Huang, Yongjian Guo, Liteng Lin, Kang-Shun Zhu
Inhibition of CEMIP potentiates the effect of sorafenib on metastatic hepatocellular carcinoma by reducing the stiffness of lung metastases. Cell death & disease 14 (1) (2023)
Xiao-Hui Wang, Chang-Jun Liu, Hao-Quan Wen, Xiao-Hui Duan, Yu-Qing Jiao, Yu-Jiang Liu, Min-Shan Chen, Kang-Shun Zhu, Xian-Hai Mao, Qun-Fang Zhou
Effectiveness of lenvatinib plus immune checkpoint inhibitors in primary advanced hepatocellular carcinoma beyond oligometastasis. Clinical and translational medicine 13 (3) (2023)
Xiao-Hui Wang, Chang-Jun Liu, Hao-Quan Wen, Xiao-Hui Duan, Yu-Qing Jiao, Yu-Jiang Liu, Min-Shan Chen, Kang-Shun Zhu, Xian-Hai Mao, Qun-Fang Zhou
Effectiveness of lenvatinib plus immune checkpoint inhibitors in primary advanced hepatocellular carcinoma beyond oligometastasis. Clinical and translational medicine 13 (3) (2023)
Jingjun Huang, Yongjian Guo, Wensou Huang, Xiaotao Hong, Yi Quan, Liteng Lin, Jingwen Zhou, Licong Liang, Yaqin Zhang, Juan Zhou, Mingyue Cai, Kang-Shun Zhu
Regorafenib Combined with PD-1 Blockade Immunotherapy versus Regorafenib as Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Study. Journal of hepatocellular carcinoma 9 (2022)
Jingjun Huang, Wensou Huang, Meixiao Zhan, Yongjian Guo, Licong Liang, Mingyue Cai, Liteng Lin, Mingji He, Hui Lian, Ligong Lu, Kang-Shun Zhu
Drug-Eluting Bead Transarterial Chemoembolization Combined with FOLFOX-Based Hepatic Arterial Infusion Chemotherapy for Large or Huge Hepatocellular Carcinoma. Journal of hepatocellular carcinoma 8 (2021)
Liteng Lin, Hengye Gong, Rui Li, Jingjun Huang, Mingyue Cai, Tian Lan, Wensou Huang, Yongjian Guo, Zhimei Zhou, Yongcheng An, Zhiwei Chen, Licong Liang, Yong Wang, Xin-Tao Shuai, Kang-Shun Zhu
Nanodrug with ROS and pH Dual-Sensitivity Ameliorates Liver Fibrosis via Multicellular Regulation. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 7 (7) (2020)
Liteng Lin, Rui Li, Mingyue Cai, Jingjun Huang, Wensou Huang, Yongjian Guo, Liuhong Yang, Guizhi Yang, Tian Lan, Kang-Shun Zhu
Andrographolide Ameliorates Liver Fibrosis in Mice: Involvement of TLR4/NF-κB and TGF-β1/Smad2 Signaling Pathways. Oxidative medicine and cellular longevity 2018 (2018)
Xiaoli Zhu, Zhao Ran, Wanci Li, Wansheng Wang, Kang-Shun Zhu, Wensou Huang, Xin Gao
Method for Calculating the Bending Angle of Puncture Needle in Preoperative Planning for Transjugular Intrahepatic Portal Systemic Shunt (TIPS). Computational and mathematical methods in medicine 2018 (2018)
Mingyue Cai, Wensou Huang, Chaoshuang Lin, Zhengran Li, Jiesheng Qian, Mingsheng Huang, Zhaolin Zeng, Jingjun Huang, Hong Shan, Kang-Shun Zhu
Partial splenic embolization for thrombocytopenia in liver cirrhosis: predictive factors for platelet increment and risk factors for major complications. European radiology 26 (2) (2015)